Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Post-approval studies (Phase 4)Study completedNCT02521974
What this trial is testing

Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children

Who this might be right for
Adverse Event Following Immunisation
Fidec Corporation 164
Post-approval studies (Phase 4)Study completedNCT01475539
What this trial is testing

Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine

Who this might be right for
PolioPoliomyelitis
Sanofi Pasteur, a Sanofi Company 456
Post-approval studies (Phase 4)Study completedNCT00389857
What this trial is testing

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 31
Testing effectiveness (Phase 2)Study completedNCT02038881
What this trial is testing

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Who this might be right for
Smallpox
Bavarian Nordic 87
Early research (Phase 1)Study completedNCT03718130
What this trial is testing

Combination HTNV and PUUV DNA Vaccine

Who this might be right for
Hantaan Virus Disease, Puumala Virus
U.S. Army Medical Research and Development Command 61
Post-approval studies (Phase 4)Study completedNCT00311428
What this trial is testing

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Who this might be right for
Influenza
Novartis 270
Early research (Phase 1)Study completedNCT01782300
What this trial is testing

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT01900899
What this trial is testing

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Who this might be right for
Infections, Meningococcal
Pfizer 184
Not applicableStudy completedNCT02808832
What this trial is testing

An HPV Vaccine Provider Intervention in Safety Net Clinics

Who this might be right for
Human PapillomavirusUterine Cervical Neoplasms
Meharry Medical College 806
Testing effectiveness (Phase 2)Study completedNCT00081809
What this trial is testing

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Who this might be right for
Lymphoma, FollicularLymphoma, Small Lymphocytic
Agenus Inc. 35
Early research (Phase 1)Study completedNCT03109600
What this trial is testing

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Who this might be right for
Safety Issues
PT Bio Farma 100
Early research (Phase 1)Study completedNCT00857311
What this trial is testing

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 17
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT02840487
What this trial is testing

Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults

Who this might be right for
Prevention of Zika InfectionZika-Specific Immune Response
National Institute of Allergy and Infectious Diseases (NIAID) 80
Early research (Phase 1)Study completedNCT03820414
What this trial is testing

Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects

Who this might be right for
Herpes ZosterVaricella Zoster
Curevo Inc 90
Testing effectiveness (Phase 2)Study completedNCT00316628
What this trial is testing

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Who this might be right for
Influenza
Novartis 50
Testing effectiveness (Phase 2)Study completedNCT00914732
What this trial is testing

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 523
Large-scale testing (Phase 3)Study completedNCT01777321
What this trial is testing

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation